$LFST
LifeStance Health Group, Inc.

2021 Q3 Form 10-Q Financial Statement

#000095017021001308 Filed on August 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $173.8M $160.5M $38.56M
YoY Change 70.46% 316.42%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $162.9M $85.48M $7.192M
YoY Change 734.15% 1088.53%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.965M $3.070M $657.0K
YoY Change 140.3% 367.28%
% of Gross Profit
Operating Expenses $298.5M $207.6M $35.50M
YoY Change 200.63% 484.85%
Operating Profit -$124.7M -$47.05M $3.060M
YoY Change -4732.78% -1637.42%
Interest Expense $3.503M $23.17M $1.340M
YoY Change -45.44% 1629.4%
% of Operating Profit 43.79%
Other Income/Expense, Net -$4.535M -$26.78M -$33.68M
YoY Change -35.76% -20.5%
Pretax Income -$129.2M -$73.82M -$30.62M
YoY Change 2857.94% 141.09%
Income Tax -$8.751M -$3.788M $3.022M
% Of Pretax Income
Net Earnings -$120.5M -$70.03M -$27.60M
YoY Change 3556.71% 153.76%
Net Earnings / Revenue -69.29% -43.62% -71.58%
Basic Earnings Per Share
Diluted Earnings Per Share -$350.8K -$223.4K -$0.82
COMMON SHARES
Basic Shares Outstanding 374.1M 313.5K
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $212.1M $276.2M
YoY Change
Cash & Equivalents $212.1M $276.2M $27.22M
Short-Term Investments
Other Short-Term Assets $46.14M $27.80M
YoY Change
Inventory
Prepaid Expenses
Receivables $70.06M $60.07M
Other Receivables $0.00 $0.00
Total Short-Term Assets $328.3M $364.1M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $115.0M $91.80M
YoY Change
Goodwill $1.160B $1.139B $0.00
YoY Change
Intangibles $308.0M $316.5M
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.388M $3.300M
YoY Change
Total Long-Term Assets $1.586B $1.550B
YoY Change
TOTAL ASSETS
Total Short-Term Assets $328.3M $364.1M
Total Long-Term Assets $1.586B $1.550B
Total Assets $1.915B $1.914B
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.074M $9.958M
YoY Change
Accrued Expenses $85.93M $89.16M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.323M $1.619M
YoY Change
Total Short-Term Liabilities $105.2M $112.6M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $157.4M $157.1M
YoY Change
Other Long-Term Liabilities $22.89M $15.70M
YoY Change
Total Long-Term Liabilities $264.7M $257.2M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $105.2M $112.6M
Total Long-Term Liabilities $264.7M $257.2M
Total Liabilities $369.9M $369.8M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$249.0M -$128.6M
YoY Change
Common Stock $1.794B $1.673B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.545B $1.545B
YoY Change
Total Liabilities & Shareholders Equity $1.915B $1.914B
YoY Change

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$120.5M -$70.03M -$27.60M
YoY Change 3556.71% 153.76%
Depreciation, Depletion And Amortization $3.965M $3.070M $657.0K
YoY Change 140.3% 367.28%
Cash From Operating Activities -$14.21M -$16.92M -$37.32M
YoY Change -5.83% -54.67%
INVESTING ACTIVITIES
Capital Expenditures -$24.01M -$20.72M $5.120M
YoY Change 27.63% -504.73%
Acquisitions $22.38M
YoY Change
Other Investing Activities -$19.57M -$38.37M -$670.0M
YoY Change -97.12% -94.27%
Cash From Investing Activities -$43.58M -$59.09M -$671.2M
YoY Change -93.77% -91.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $138.5M
YoY Change
Cash From Financing Activities -6.270M 312.7M 722.3M
YoY Change -100.84% -56.71%
NET CHANGE
Cash From Operating Activities -14.21M -16.92M -37.32M
Cash From Investing Activities -43.58M -59.09M -671.2M
Cash From Financing Activities -6.270M 312.7M 722.3M
Net Change In Cash -64.06M 236.7M 13.80M
YoY Change -300.07% 1614.67%
FREE CASH FLOW
Cash From Operating Activities -$14.21M -$16.92M -$37.32M
Capital Expenditures -$24.01M -$20.72M $5.120M
Free Cash Flow $9.803M $3.807M -$42.44M
YoY Change 163.17% -108.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
dei Entity Central Index Key
EntityCentralIndexKey
0001845257
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40478
dei Entity Registrant Name
EntityRegistrantName
LifeStance Health Group, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1832801
dei Entity Address Address Line1
EntityAddressAddressLine1
4800 N. Scottsdale Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 6000
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85251
dei City Area Code
CityAreaCode
425
dei Local Phone Number
LocalPhoneNumber
279-8500
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
LFST
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
276187000
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
374148648
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18829000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60069000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43706000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27804000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13745000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
364060000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
76280000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91799000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59349000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
316534000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
332796000
CY2021Q2 us-gaap Goodwill
Goodwill
1138734000
CY2020Q4 us-gaap Goodwill
Goodwill
1098659000
CY2021Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
3300000
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2647000
CY2021Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1550367000
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1493451000
CY2021Q2 us-gaap Assets
Assets
1914427000
CY2020Q4 us-gaap Assets
Assets
1569731000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9958000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7688000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
50380000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
38024000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
38783000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14685000
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
10876000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
10563000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2561000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4961000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
112558000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
75921000
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
157067000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
362534000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15704000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11363000
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3247000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5851000
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
81219000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
81226000
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
257237000
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
460974000
CY2021Q2 us-gaap Liabilities
Liabilities
369795000
CY2020Q4 us-gaap Liabilities
Liabilities
536895000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
0
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
374149000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
374149000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
0
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
0
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
3742000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1669480000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1452000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128590000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13125000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1544632000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
997836000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1914427000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1569731000
CY2021Q2 us-gaap Revenues
Revenues
160549000
us-gaap Revenues
Revenues
303681000
CY2020Q2 us-gaap Revenues
Revenues
45453000
CY2020Q2 us-gaap Revenues
Revenues
38555000
us-gaap Revenues
Revenues
111661000
CY2021Q2 us-gaap Other General Expense
OtherGeneralExpense
109341000
us-gaap Other General Expense
OtherGeneralExpense
208475000
CY2020Q2 us-gaap Other General Expense
OtherGeneralExpense
31275000
CY2020Q2 us-gaap Other General Expense
OtherGeneralExpense
27143000
us-gaap Other General Expense
OtherGeneralExpense
78777000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
85479000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
118130000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8642000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7192000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20854000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12774000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
25002000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5432000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1160000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3335000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
207594000
us-gaap Operating Expenses
OperatingExpenses
351607000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
45349000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
35495000
us-gaap Operating Expenses
OperatingExpenses
102966000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-47045000
us-gaap Operating Income Loss
OperatingIncomeLoss
-47926000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
104000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3060000
us-gaap Operating Income Loss
OperatingIncomeLoss
8695000
CY2021Q2 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
-250000
lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
-557000
CY2020Q2 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
-51000
CY2020Q2 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
-32000
lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
322000
CY2021Q2 lfst Transaction Costs
TransactionCosts
-1996000
lfst Transaction Costs
TransactionCosts
-3530000
CY2020Q2 lfst Transaction Costs
TransactionCosts
-181000
CY2020Q2 lfst Transaction Costs
TransactionCosts
-32294000
lfst Transaction Costs
TransactionCosts
-33247000
CY2021Q2 us-gaap Interest Expense
InterestExpense
23174000
us-gaap Interest Expense
InterestExpense
31806000
CY2020Q2 us-gaap Interest Expense
InterestExpense
5562000
CY2020Q2 us-gaap Interest Expense
InterestExpense
1340000
us-gaap Interest Expense
InterestExpense
3020000
CY2021Q2 us-gaap Other Expenses
OtherExpenses
1356000
us-gaap Other Expenses
OtherExpenses
1445000
CY2020Q2 us-gaap Other Expenses
OtherExpenses
22000
CY2020Q2 us-gaap Other Expenses
OtherExpenses
14000
us-gaap Other Expenses
OtherExpenses
14000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26776000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-37338000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5816000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-33680000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-35959000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-73821000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-85264000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5712000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30620000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27264000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3788000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6549000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1370000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3022000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2319000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-70033000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-78715000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4342000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27598000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24945000
CY2021Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0
us-gaap Dividends Preferred Stock
DividendsPreferredStock
0
CY2020Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0
CY2020Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
217000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
662000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-70033000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-115465000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4342000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-300397000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-298189000
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.22
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.37
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.01
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
313536000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
309559000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
297237000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
954009000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-70033000
CY2021Q2 lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
1486000
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
71750000
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
9000000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29515000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1544632000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
997836000
us-gaap Net Income Loss
NetIncomeLoss
-78715000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000000
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
36750000
lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
1486000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
71750000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
9000000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30120000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1544632000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
0
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-4342000
CY2020Q2 lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
4500000
CY2020Q2 lfst Issuance Of Common Units For Convertible Promissory Note Conversion
IssuanceOfCommonUnitsForConvertiblePromissoryNoteConversion
511000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
292000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
981369000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-164202000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-27598000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-464382000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-166355000
us-gaap Net Income Loss
NetIncomeLoss
-24945000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-464382000
us-gaap Profit Loss
ProfitLoss
-78715000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-4342000
us-gaap Profit Loss
ProfitLoss
-24945000
lfst Endowment Of Shares
EndowmentOfShares
9000000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
25002000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5432000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3335000
CY2020Q2 lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
-51000
lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
322000
us-gaap Share Based Compensation
ShareBasedCompensation
30120000
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
292000
us-gaap Share Based Compensation
ShareBasedCompensation
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2866000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2345000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
5620000
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3066000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1081000
CY2020Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
135000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
215000
lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
-557000
CY2020Q2 lfst Endowment Of Shares
EndowmentOfShares
0
lfst Endowment Of Shares
EndowmentOfShares
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11831000
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2463000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5122000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14964000
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4394000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4526000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2261000
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
891000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1638000
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
9580000
CY2020Q2 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-3844000
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
8753000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
15283000
CY2020Q2 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-35007000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
40031000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7006000
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37317000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13436000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31803000
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5120000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12804000
lfst Payments To Acquire Predecessor Net Of Cash Acquired
PaymentsToAcquirePredecessorNetOfCashAcquired
-0
CY2020Q2 lfst Payments To Acquire Predecessor Net Of Cash Acquired
PaymentsToAcquirePredecessorNetOfCashAcquired
643717000
lfst Payments To Acquire Predecessor Net Of Cash Acquired
PaymentsToAcquirePredecessorNetOfCashAcquired
-0
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
39126000
CY2020Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
22376000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12274000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-70929000
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-671213000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
1000000
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
0
us-gaap Payments For Repurchase Of Redeemable Convertible Preferred Stock
PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
0
lfst Proceeds From Contributions From Members
ProceedsFromContributionsFromMembers
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25078000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
554169000
CY2020Q2 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
0
CY2020Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2020Q2 lfst Proceeds From Contributions From Members
ProceedsFromContributionsFromMembers
633585000
lfst Proceeds From Contributions From Members
ProceedsFromContributionsFromMembers
0
CY2020Q2 us-gaap Payments For Repurchase Of Redeemable Convertible Preferred Stock
PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
0
us-gaap Payments For Repurchase Of Redeemable Convertible Preferred Stock
PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
1000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
98800000
CY2020Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
235900000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
74350000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2360000
CY2020Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6411000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
650000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
310729000
CY2020Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
138540000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
18222000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
5587000
CY2020Q2 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
2200000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
19093000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
335293000
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
722334000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35385000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
257358000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13804000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23743000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18829000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3481000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
276187000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13804000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27224000
us-gaap Interest Paid Net
InterestPaidNet
24889000
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
2773000
us-gaap Interest Paid Net
InterestPaidNet
2857000
us-gaap Income Taxes Paid
IncomeTaxesPaid
900000
CY2020Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
25000
lfst Unpaid Deferred Offering Costs Included In Accounts Payable And Other Accrued Expenses
UnpaidDeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedExpenses
5264000
CY2020Q2 lfst Unpaid Deferred Offering Costs Included In Accounts Payable And Other Accrued Expenses
UnpaidDeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedExpenses
0
lfst Unpaid Deferred Offering Costs Included In Accounts Payable And Other Accrued Expenses
UnpaidDeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedExpenses
0
lfst Equipment Financed Through Capital Leases
EquipmentFinancedThroughCapitalLeases
14000
CY2020Q2 lfst Equipment Financed Through Capital Leases
EquipmentFinancedThroughCapitalLeases
1000
lfst Equipment Financed Through Capital Leases
EquipmentFinancedThroughCapitalLeases
415000
lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
2739000
CY2020Q2 lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
3191000
lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
3788000
lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
10233000
CY2020Q2 lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
2694000
lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
2718000
lfst Issuance Of Common Units For Convertible Promissory Note Conversion
IssuanceOfCommonUnitsForConvertiblePromissoryNoteConversion
0
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-01-28
lfst Reclassification Of Redeemable Investor Units To Additional Paid In Capital Due To Conversion
ReclassificationOfRedeemableInvestorUnitsToAdditionalPaidInCapitalDueToConversion
71648000
CY2021Q2 lfst Reclassification Of Members Capital Due To Conversion
ReclassificationOfMembersCapitalDueToConversion
1008688000
lfst Reclassification Of Common Stock Due To Conversion
ReclassificationOfCommonStockDueToConversion
3408000
CY2020Q2 lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
4500000
lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
0
CY2020Q2 lfst Issuance Of Common Units For Convertible Promissory Note Conversion
IssuanceOfCommonUnitsForConvertiblePromissoryNoteConversion
511000
lfst Issuance Of Common Units For Convertible Promissory Note Conversion
IssuanceOfCommonUnitsForConvertiblePromissoryNoteConversion
0
lfst Issuance Of Common Units For Acquisitions Of Businesses
IssuanceOfCommonUnitsForAcquisitionsOfBusinesses
1486000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
3799000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
238000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Accounting Estimates</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2021Q2 lfst Acquisition Of Non Medical Assets
AcquisitionOfNonMedicalAssets
1
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.56;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">New Accounting Pronouncements Not Yet Adopted</span><span style="color:rgba(0,0,0,1);font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In February 2016, the FASB issued ASU 2016-02, </span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases (Topic 842)</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and also issued subsequent amendments to the initial guidance: ASU 2017-13, ASU 2018-10, ASU 2018-11, ASU 2018-20, ASU 2019-01, ASU 2020-02, and ASU 2020-05 (collectively, “ASC 842”). ASC 842 outlines a comprehensive lease accounting model and supersedes the</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">current lease guidance. The new guidance requires lessees to recognize lease liabilities and corresponding right-of-use assets for all leases with lease terms of greater than 12 months. It also changes the definition of a lease and expands the disclosure requirements of lease arrangements. ASC 842 is effective for private entities for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022, inclusive of a one year deferral provided by ASU 2020-05. ASC 842 must be adopted using a modified retrospective method and early adoption is permitted. The Company is in the process of determining the impact of the adoption of ASC 842 on the Company’s consolidated financial statements and disclosures. However, given the Company’s current operating lease portfolio (see Note 16) the Company expects the recognition of the right-of-use assets and lease liabilities to have a material impact on the Company’s consolidated balance sheets.</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Financial Instruments (Topic 326)-Measurement of Credit Losses on Financial Instruments</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (“ASU 2016-13”). ASU 2016-13 requires an entity to utilize a new impairment model known as the current expected credit loss (“CECL”) model to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. ASU 2016-13 also requires new disclosures for financial assets measured at amortized cost, loans and available-for-sale debt securities. ASU 2016-13 is effective for private entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. ASU 2016-03 will apply as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company is in the process of evaluating the impact of the adoption of ASU 2016-13 on the Company’s consolidated financial statements and disclosures.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Simplifying the Accounting for Income Taxes</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (“ASU 2019-12”). ASU 2019-12 simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12 is effective for private entities for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted, including adoption in any interim period for public business entities for periods for which financial statements have not yet been issued and all other entities for periods for which financial statements have not yet been made available for issuance. The Company is in the process of evaluating the impact of the adoption of ASU 2019-12 on the Company’s consolidated financial statements and disclosures.</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (“ASU 2020-04”). This guidance provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions, subject to meeting certain criteria, that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. The amendments issued in March 2020 provide optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in ASU 2020-04 are effective for all entities as of March 12, 2020, through December 31, 2022. The Company is still evaluating the impact of adopting ASU 2020-04 on its consolidated financial statements and disclosures.</span></p>
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
381823000
lfst Business Combination Cash Consideration
BusinessCombinationCashConsideration
670941000
CY2021Q2 us-gaap Escrow Deposit
EscrowDeposit
4500000
CY2020Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
126106000
CY2020Q2 us-gaap Goodwill
Goodwill
926658000
CY2021Q2 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
10
lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
11
CY2020Q2 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
4
CY2020Q2 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
3
lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
7
CY2021Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
40612000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
41312000
CY2020Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
23625000
CY2020Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
4103000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
12369000
CY2021Q2 us-gaap Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
325000
us-gaap Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
325000
CY2020Q2 us-gaap Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
0
CY2020Q2 us-gaap Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
0
us-gaap Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
0
CY2021Q2 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
0
us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
0
CY2020Q2 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
0
CY2020Q2 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
0
us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
500000
CY2021Q2 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
44354000
us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
45862000
CY2020Q2 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
31316000
CY2020Q2 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
4980000
us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
16657000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
2008000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
2048000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
1248000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
212000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
221000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
227000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
77000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
3515000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
3382000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
293000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
1344000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
676000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
694000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
590000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
79000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
234000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
9000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
68000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Deposits
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDeposits
86000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Deposits
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDeposits
91000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Deposits
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDeposits
192000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Deposits
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDeposits
19000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Deposits
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDeposits
87000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
2936000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
3061000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
3144000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
308000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
2080000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
40170000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
41287000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
24659000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
4324000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
14099000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
49612000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
51207000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
33292000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
5244000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
18150000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
5258000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
5345000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
1976000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
264000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
1493000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
5258000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
5345000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
1976000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
264000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
1493000
CY2021Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
44354000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
45862000
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
2080000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
31316000
CY2020Q2 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
4980000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
16657000
CY2021Q2 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
2936000
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
3061000
CY2020Q2 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
3144000
CY2020Q2 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
308000
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
359127000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-42593000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
316534000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
356066000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-23270000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
332796000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9704000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19323000
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4669000
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
503000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1435000
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
101910000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
63781000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10111000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4432000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91799000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59349000
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3070000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5679000
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
763000
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
657000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1900000
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
14123000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
16414000
CY2021Q2 lfst Financial Assets And Liabilities Fair Value Recurring
FinancialAssetsAndLiabilitiesFairValueRecurring
0
CY2020Q2 us-gaap Goodwill
Goodwill
0
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
2977000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
169024000
CY2020Q4 us-gaap Goodwill
Goodwill
1098659000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
41287000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-1212000
CY2021Q2 us-gaap Goodwill
Goodwill
1138734000
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
161892000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
373820000
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1619000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3738000
CY2021Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3206000
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7548000
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
157067000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
362534000
CY2021Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
190167000
CY2020Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
458685000
CY2021Q2 lfst Voluntary Prepayment Of Borrowings Outstanding
VoluntaryPrepaymentOfBorrowingsOutstanding
294000000
CY2021Q2 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
14444000
CY2020Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
2689000
CY2020Q2 us-gaap Long Term Debt Maturities Repayment Terms
LongTermDebtMaturitiesRepaymentTerms
May 14, 2026
CY2021Q2 us-gaap Interest Expense
InterestExpense
23174000
us-gaap Interest Expense
InterestExpense
31806000
CY2020Q2 us-gaap Interest Expense
InterestExpense
5562000
CY2020Q2 us-gaap Interest Expense
InterestExpense
1340000
us-gaap Interest Expense
InterestExpense
3020000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
809000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
1619000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
1619000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
1619000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
1619000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
154607000
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
161892000
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
160549000
CY2021Q2 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
303681000
lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
45453000
CY2020Q2 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
38555000
CY2020Q2 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
111661000
lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3788000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6549000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1370000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3022000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2319000
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.051
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.077
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.240
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.099
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.085
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0014
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0014
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0020
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4000
CY2021Q2 lfst Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Time To Liquidity Event
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTimeToLiquidityEvent
P2Y
lfst Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Time To Liquidity Event
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTimeToLiquidityEvent
P2Y
CY2020Q2 lfst Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Time To Liquidity Event
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTimeToLiquidityEvent
P3Y
CY2021Q2 us-gaap Warrants And Rights Outstanding Measurement Input
WarrantsAndRightsOutstandingMeasurementInput
0
CY2021Q2 us-gaap Warrants And Rights Outstanding Measurement Input
WarrantsAndRightsOutstandingMeasurementInput
0
CY2020Q2 us-gaap Warrants And Rights Outstanding Measurement Input
WarrantsAndRightsOutstandingMeasurementInput
20.00
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.13
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
0.13
CY2021Q2 lfst Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Conversion
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsConversion
0.13
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.13
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.13
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.16
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.13
lfst Share Based Compensation Arrangement By Share Based Payment Award Options Conversion Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionWeightedAverageGrantDateFairValue
0.13
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.13
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.13
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.13
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Unit Outstanding
CommonUnitOutstanding
0
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1044509000
CY2020Q4 us-gaap Common Unit Outstanding
CommonUnitOutstanding
1044509000
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1687000
CY2021Q2 lfst Vested Of Common Stock Profit Interest
VestedOfCommonStockProfitInterest
17920000
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
723267000
lfst Common Units Initial Public Offering In Period
CommonUnitsInitialPublicOfferingInPeriod
32800000
lfst Endowment To The Lifestance Health Foundation
EndowmentToTheLifestanceHealthFoundation
500000
CY2021Q2 us-gaap Common Unit Outstanding
CommonUnitOutstanding
374149000
CY2020 lfst Fair Value Of Mezzanine Equity
FairValueOfMezzanineEquity
0
CY2021Q2 lfst Fair Value Of Mezzanine Equity
FairValueOfMezzanineEquity
36750000
lfst Number Of Office Facilities
NumberOfOfficeFacilities
14
lfst Lease Expiration Year
LeaseExpirationYear
2034
CY2021Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
661000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1197000
CY2020Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
107000
CY2020Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
148000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
388000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1376000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2678000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2384000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2102000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2011000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
682000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
11233000
CY2021Q2 lfst Termination Fee
TerminationFee
1213000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1356000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1445000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14000
CY2020Q4 lfst Business Combination Contingent Consideration
BusinessCombinationContingentConsideration
16414000
lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
2739000
lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-5587000
lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
557000
CY2021Q2 lfst Business Combination Contingent Consideration
BusinessCombinationContingentConsideration
14123000
CY2020Q2 lfst Business Combination Contingent Consideration
BusinessCombinationContingentConsideration
0
CY2020Q2 lfst Business Combination Additions Related To Tpg Acquisition
BusinessCombinationAdditionsRelatedToTPGAcquisition
9909000
CY2020Q2 lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
3191000
CY2020Q2 lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-2200000
CY2020Q2 lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
51000
CY2020Q2 lfst Business Combination Contingent Consideration
BusinessCombinationContingentConsideration
10951000
CY2019Q4 lfst Business Combination Contingent Consideration
BusinessCombinationContingentConsideration
25536000
lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
3788000
lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-19093000
lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
-322000
CY2020Q2 lfst Business Combination Contingent Consideration
BusinessCombinationContingentConsideration
9909000
lfst Operating Lease Expiration Year
OperatingLeaseExpirationYear
2029
CY2021Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
7526000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
14104000
CY2020Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2356000
CY2020Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1316000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4210000
us-gaap Malpractice Insurance Coverage Floor
MalpracticeInsuranceCoverageFloor
8000000
us-gaap Malpractice Insurance Annual Coverage Limit
MalpracticeInsuranceAnnualCoverageLimit
12000000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-70033000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-115465000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4342000
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
313536000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
309559000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
297237000
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.22
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.37
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.01

Files In Submission

Name View Source Status
0000950170-21-001308-index-headers.html Edgar Link pending
0000950170-21-001308-index.html Edgar Link pending
0000950170-21-001308.txt Edgar Link pending
0000950170-21-001308-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lfst-20210630.htm Edgar Link pending
lfst-20210630.xsd Edgar Link pending
lfst-20210630ex31_1.htm Edgar Link pending
lfst-20210630ex31_2.htm Edgar Link pending
lfst-20210630ex32_1.htm Edgar Link pending
lfst-20210630ex32_2.htm Edgar Link pending
lfst-20210630_cal.xml Edgar Link unprocessable
lfst-20210630_def.xml Edgar Link unprocessable
lfst-20210630_htm.xml Edgar Link completed
lfst-20210630_lab.xml Edgar Link unprocessable
lfst-20210630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending